Drugs & medicalClass III

Ascend Laboratories, LLC recalls Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem…

Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability

Read the official notice →
Date
2026-08-05
Country
United States
Brand
Ascend Laboratories
Product
Dabigatran Etexilate Capsules, 75 mg, 60-count (6x10)blister pack further packaged in a carton, Rx only, Manufactured by: Alkem…
Classification
Class III
Units
USA Nationwide
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Ascend Laboratories recalls

  1. 2026-07-29
  2. US
    Drugs & medicalClass III

    Ascend Laboratories, LLC recalls Dabigatran etexilate Capsules, 150 mg, 20-count carton (2x10), Rx only, Manufactured by: Alkem Laboratories, Mumbai, INDIA, Distributed…

    Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.

    FDA · DrugAscend Laboratories, LLCUSA NationwideOfficial notice →
  3. US
    Drugs & medicalClass II

    Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd.,…

    Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications

    FDA · DrugAscend Laboratories, LLCNationwide in the USAOfficial notice →
  4. 2026-06-17
  5. US
    Drugs & medicalClass II

    Ascend Laboratories, LLC recalls Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd.,…

    Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

    FDA · DrugAscend Laboratories, LLCNationwide in the USAOfficial notice →
  6. 2026-06-10
  7. US
    Drugs & medicalClass II

    Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bottle, Manufactured by: Alkem Laboratories Ltd., India,…

    Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

    FDA · DrugAscend Laboratories, LLCU.S.A. NationwideOfficial notice →
  8. 2026-05-20
  9. US
  10. 2025-10-22
  11. US
All 24 Ascend Laboratories recalls →

Other drugs & medical recalls in the United States

  1. 2026-08-05
  2. US
    Drugs & medicalClass II

    Terex Utilities recalls Power Over Fiber Base Module

    Device not certified - no laser product report was filed with CDRH prior to distribution. Product label incorrectly states device is "Class IV", although Class 1 is appropriate for device. Improperly labeled - omitted…

    FDA · DeviceTerex UtilitiesU.S. Nationwide Distribution and International DistributionOfficial notice →
  3. US
    Drugs & medicalClass I

    ResMed Ltd. recalls Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for…

    Due to a Supercapacitor electrolyte leakage on Printed Circuit Board Assembly (PCBA) may damage the charger chip, causing fail-safe state and interruption of ventilation therapy.

    FDA · DeviceResMed Ltd.Worldwide - U.S. Nationwide distribution including in the states of AK, AL,…Official notice →
  4. US
    Drugs & medicalClass II

    PHILIPS MEDICAL SYSTEMS recalls IQon Spectral CT IQon Spectral CT Upgrades

    The clinical CT scan may not automatically trigger after the Bolus Tracking scan and may need to be triggered manually. Additional Bolus Tracking shots may occur. This may result in the clinical acquisition being…

    FDA · DevicePHILIPS MEDICAL SYSTEMSUS Nationwide Distribution including Puerto RicoOfficial notice →
  5. US
  6. US
    Drugs & medicalClass II

    Glenmark Pharmaceuticals Inc., USA recalls Azelaic Acid Gel, 15%, 50 gram tubes, For Topical Use only, Rx only, Distributed by: Glenmark Pharmaceuticals Inc., USA,…

    CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.

    FDA · DrugGlenmark Pharmaceuticals Inc., USANationwide within the United States.Official notice →
  7. US
    Drugs & medicalClass II

    MICRO LABS USA INC recalls Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India,…

    Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.

    FDA · DrugMICRO LABS USA INCNationwide in the USA.Official notice →
See all drugs & medical recalls →